Literature DB >> 826969

Stimulant actions of delta9-tetrahydrocannabinol in mice.

M A Evans, R D Harbison, D J Brown, R B Forney.   

Abstract

delta9-Tetrahydrocannabinol (THC) augments the locomotor activity produced by methamphetamine (0.5 mg/kg) in aggregated mice. THC-induced augmentation was dose related and lasted for a two-hour period. Maximal effective dosage of THC was 15 mg/kg with higer dosages of 30 and 60 mg/kg producing a decrease from maximum in locomotor activity. THC, 15 mg/kg, also increases locomotor activity among aggregated animals treated with saline. However, the increase was much less than the methamphetamine augmentation. In similar studies using isolated mice THC produced only a dose-related decrease in locomtor activity among both methamphetamine-treated and saline-treated animals. THC, 60 mg/kg, had no effect on methamphetamine-induced lethality in aggregated mice. However, at 15 mg/kg, THC significantly enhanced the lethality of methamphetamine. THC did not alter methamphetamine lethality in isolated mice. Distribution studies using 14C-methamphetamine indicated that neither THC nor isolation of animals affected tissue concentration or disappearance of 14C material. Previously reported synergistic interaction between amphetamine and THC is related to aggregation of the animals rather than drug treatment. Since THC at low doses can stimulate motor activity in saline-treated animals, amphetamine may act only to amplify the behavioral activity produced by low doses of THC.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826969     DOI: 10.1007/BF00426840

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.

Authors:  P F Anderson; D M Jackson; G B Chesher; R Malor
Journal:  Psychopharmacologia       Date:  1975-07-23

2.  OBSERVATIONS ON THE PHARMACOLOGICAL ACTIONS OF CANNABIS INDICA. II.

Authors:  B C BOSE; A Q SAIFI; A W BHAGWAT
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-01-01

3.  Some pharmacological effects of two tetrahydrocannabinols.

Authors:  R DAGIRMANJIAN; E S BOYD
Journal:  J Pharmacol Exp Ther       Date:  1962-01       Impact factor: 4.030

4.  Impairment of performance with low doses of marihuana.

Authors:  M A Evans; R Martz; D J Brown; B E Rodda; G F Kiplinger; L Lemberger; R B Forney
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

5.  Pharmacological effects of two active constituents of marihuana.

Authors:  H I Bicher; R Mechoulam
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-03

6.  The effect of delta9 tetrahydrocannabinol on amphetamine induced lethality in aggregated mice.

Authors:  J F Howes
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-11

7.  Marihuana on locomotor activity: biphasic effect and tolerance development.

Authors:  W M Davis; J E Moreton; W T King; H B Pace
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-01

8.  Interactions of delta-tetrahydrocannabinol with barbiturates and methamphetamine.

Authors:  R K Kubena; H Barry
Journal:  J Pharmacol Exp Ther       Date:  1970-05       Impact factor: 4.030

9.  Acute toxicity of delta-9-tetrahydrocannabinol in rats and mice.

Authors:  R N Phillips; R F Turk; R B Forney
Journal:  Proc Soc Exp Biol Med       Date:  1971-01

10.  Adverse reactions associated with Cannabis products in India.

Authors:  W Grossman
Journal:  Ann Intern Med       Date:  1969-03       Impact factor: 25.391

View more
  2 in total

1.  Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice.

Authors:  I H Ayhan; S Kaymakçalan; F C Tulunay
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

2.  Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.

Authors:  Bogna Ignatowska-Jankowska; Jenny L Wilkerson; Mohammed Mustafa; Rehab Abdullah; Micah Niphakis; Jenny L Wiley; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2015-03-11       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.